Skip to Main Content

Paper Details

Clinical Outcomes With Metformin and Sulfonylurea Therapies Among Patients With Heart Failure and Diabetes.
JACC Heart Fail
13
2022
Diabetes, HF, HHF, Heart Failure, Metformin, Patients, Sulfonylurea, diabetes, gastrointestinal bleed, heart failure, influenza, metformin, patients, sulfonylurea, sulfonylureas, urinary tract infection
Author NameAffiliation
Adam D DeVoreDuke University School of Medicine, USA Duke Clinical Research Institute
Gary Michael FelkerDuke University School of Medicine, USA Duke Clinical Research Institute
Adrian F HernandezDuke University School of Medicine, USA Duke Clinical Research Institute
Paul A Heidenreich
Pamela N PetersonUniversity of Colorado, Denver Health Medical Center
Gregg C FonarowAhmanson-university of california los angeles Cardiomyopathy Center, David Geffen School of Medicine, University of California-Los Angeles
Gregg C FonarowAhmanson-university of california los angeles Cardiomyopathy Center, David Geffen School of Medicine, University of California-Los Angeles
  • 1 - 7

Datasets

Release 1.2